Abstract
Cancer associated glycoconjugates are important biomarkers, as exemplified by globo-H, CA125, CA15.3 and CA27.29. However, the exact chemical structures of many such biomarkers remain unknown because of technological limitations. In this article, we propose the "immunologic mapping" of cancer glycomes based on specific immune recognition of glycan structures, which can be hypothesized theoretically, produced chemically, and examined biologically by immuno-assays. Immunologic mapping of glycans not only provides a unique perspective on cancer glycomes, but also may lead to the invention of powerful reagents for diagnosis and therapy.
Original language | English |
---|---|
Journal | Frontiers in Bioscience (Scholar Edition) |
Volume | 3 |
Pages (from-to) | 1520-32 |
Number of pages | 13 |
ISSN | 1945-0516 |
Publication status | Published - 1 Jun 2011 |